美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inspire Corporate Bond ETF

23.92

-0.0200-0.08%

盤後：23.920.00000.00%16:04 EDT

成交量：5.01萬

成交額：120.01萬

市值：3.85億

市盈率：- -

高：23.99

開：23.98

低：23.89

收：23.94

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

年虧上億、估值39億！張和勝夫婦持股46.5%的和美藥業赴港IPO

和美藥業IPO：商業化前景難言樂觀核心管線臨牀數據顯著弱於競品

艾伯維揮起拳頭

134億！中國AI雙抗首出海！華深智藥斬獲大單

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IBD"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","market":"US","secType":"STK","nameCN":"Inspire Corporate Bond ETF","latestPrice":23.92,"timestamp":1751054400000,"preClose":23.94,"halted":0,"volume":50140,"hourTrading":{"tag":"盘后","latestPrice":23.92,"preClose":23.92,"latestTime":"16:04 EDT","volume":3,"amount":71.76,"timestamp":1751054643139},"delay":0,"floatShares":16100000,"shares":16100000,"eps":0,"marketStatus":"休市中","change":-0.02,"latestTime":"06-27 16:00:00 EDT","open":23.9823,"high":23.99,"low":23.8851,"amount":1200092.146835,"amplitude":0.004382,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":23.94,"sharesOutstanding":16100000,"nav":23.9,"aum":384794608.55,"dividendRate":0.042224,"bidAskSpread":0.004268,"postHourTrading":{"tag":"盘后","latestPrice":23.92,"preClose":23.92,"latestTime":"16:04 EDT","volume":3,"amount":71.76,"timestamp":1751054643139},"volumeRatio":0.981528316364688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","floatShares":16100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.981528316364688,"shares":16100000,"dividePrice":1.01,"high":23.99,"amplitude":0.004382,"preClose":23.94,"low":23.8851,"week52Low":22.84,"pbRate":"--","week52High":25.49,"institutionHeld":0,"latestPrice":23.92,"eps":0,"divideRate":0.042224,"volume":50140,"delay":0,"ttmEps":0,"open":23.9823,"prevYearClose":23.44,"prevWeekClose":23.96,"prevMonthClose":23.74,"prevQuarterClose":23.75,"fiveDayClose":23.96,"twentyDayClose":23.73,"sixtyDayClose":23.77},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBD\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBD\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545643811","title":"年虧上億、估值39億！張和勝夫婦持股46.5%的和美藥業赴港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2545643811","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545643811?lang=zh_tw&edition=fundamental","pubTime":"2025-06-22 09:37","pubTimestamp":1750556220,"startTime":"0","endTime":"0","summary":"张氏夫妇掌握46.51%股权，董秘系实控人侄女婿从股权结构看，61岁的张和胜端坐权力中心。招股书显示，张和胜通过赣州和胜、赣州和毅控制25.22%投票权；其妻郭雪梅通过香港和美控制21.29%，夫妇合计掌控46.51%股权。在2024年亏损1.23亿元的情况下，公司薪酬单引人注目。张和胜2024年总薪酬达1024万元，其中基本薪资120.1万元，以股份为基础的支付830.4万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-06-22/doc-infaxhkr0770766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBD"],"gpt_icon":0},{"id":"2543814726","title":"和美藥業IPO：商業化前景難言樂觀 核心管線臨牀數據顯著弱於競品","url":"https://stock-news.laohu8.com/highlight/detail?id=2543814726","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543814726?lang=zh_tw&edition=fundamental","pubTime":"2025-06-13 19:52","pubTimestamp":1749815520,"startTime":"0","endTime":"0","summary":"　　近日，和美药业向港交所提交上市申请，拟根据上市规则第18A章在香港主板挂牌上市，国证国际为其独家保荐人。尽管公司核心管线已步入后期临床，但对公司招股书等相关资料进行梳理后发现，公司核心管线临床数据显著弱于竞品或市场规模有限，未来的商业化之路仍面临挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-06-13/doc-inezxtpe6365499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1718418525.SGD","BK4592","BK4550","LU1267930813.SGD","03347","IBD","BK4007","LU2129689605.HKD","LU2133065610.SGD","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU0466842654.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4585","LU2089984988.USD","LU0345770993.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0289739699.SGD","IE00BFXG1179.USD","LU0795875086.SGD","IE0009355771.USD","SG9999002232.USD","IE0002141913.USD","IE00B3PB1722.GBP","LU1032466523.USD","LU2430703178.SGD","LU0640476718.USD","LU0203345920.USD","LU0058720904.USD","IE00BBT3K403.USD","LU0345769128.USD","LU0098860793.USD","LU2505996509.AUD","LU0912757837.SGD","LU1280957306.USD","LU2602419157.SGD","LU0345769631.USD","LU1221951129.SGD","LU1244550494.USD","IE0002270589.USD","LU1732800096.USD","ADC","JNJ","BK4568","LU1066051811.HKD","BK4534","LU0985320562.USD","LU2430703095.HKD"],"gpt_icon":0},{"id":"2538211551","title":"艾伯維揮起拳頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2538211551","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538211551?lang=zh_tw&edition=fundamental","pubTime":"2025-05-25 10:59","pubTimestamp":1748141979,"startTime":"0","endTime":"0","summary":"艾伯维，作为昔日药王的拥有者，面临专利悬崖压境，举起拳头挥向新战场！表1.艾伯维免疫领域核心产品这一颓势直接拖累艾伯维2024年净利润下跌12.03%。表2.艾伯维肿瘤领域核心产品然而，随着百济神州的泽布替尼、阿斯利康的阿卡替尼等二代BTK抑制剂通过“头对头”试验证明更优疗效与安全性，伊布替尼市场份额被快速瓜分。02频繁动刀为了走出“泥潭”，艾伯维在肿瘤领域多次挥刀，转而瞄准自免与神经科学等赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABBV","IE00B4R5TH58.HKD","LU2133065610.SGD","SG9999015952.SGD","SG9999015986.USD","BK4566","LU1244550494.USD","IE00BGHQF631.EUR","LU0820561909.HKD","LU0122379950.USD","IE00B3PB1722.GBP","LU0861579265.USD","OS","LU1983299246.USD","PROC","ORR","LU0310800379.SGD","LU2087621335.USD","SG9999015945.SGD","LU0912757837.SGD","LU1244550221.USD","BK4097","LU1093756325.SGD","LU1551013425.SGD","LU0029864427.USD","BK4093","IE0009355771.USD","LU0234572021.USD","LU1162221912.USD","IE0002270589.USD","LU2237443895.HKD","SG9999003800.SGD","IBD","BK4139","LU1934455863.HKD","LU2237443382.USD","PFS","LU0949170772.SGD","LU1989772923.USD","CF","LU2129689605.HKD","IE00B19Z3B42.SGD","IE00BDGV0183.EUR","LU0211327993.USD","LU1244550577.SGD","LU0965509101.SGD","LU0203347892.USD","LU2112291526.USD","LU1585245621.USD","IE00BVYPNV92.GBP"],"gpt_icon":0},{"id":"2529476315","title":"134億！中國AI雙抗首出海！華深智藥斬獲大單","url":"https://stock-news.laohu8.com/highlight/detail?id=2529476315","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529476315?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 12:16","pubTimestamp":1745295360,"startTime":"0","endTime":"0","summary":"HXN-1003是一款靶向TL1A和IL23的双特异性抗体。而Earendil Labs的背后则是一家中国AI+药物研发公司：华深智药。此后，华深智药进一步加大了对于药物研发管线的投入。目前，全球范围内尚无靶向TL1A的药物获批上市，但已有多个针对TL1A靶点的候选药物进入临床试验阶段，并显示出积极结果。此次交易也是跨国药企与中国本土AI药企合作的典型案例，契合赛诺菲的“AI优先”战略。据悉，此前赛诺菲与Formation Bio、OpenAI的合作已初步验证AI在分子优化中的价值。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-22/doc-inetzenw7875708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBD","BK4116","RA","CD"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBD\",params:#limit:5,,,undefined,":[{"date":"2025-06-26","symbol":"IBD","amount":0.0953,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-07-01"},{"date":"2025-05-23","symbol":"IBD","amount":0.0809,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1748007000000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-28","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1747972800000,"payDate":"2025-05-28"},{"date":"2025-04-25","symbol":"IBD","amount":0.0799,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-25","defaultRemindTime":1745587800000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-30","payableDate":"2025-04-25","currency":"USD","dateTimestamp":1745553600000,"payDate":"2025-04-30"},{"date":"2025-03-27","symbol":"IBD","amount":0.092,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-04-01"},{"date":"2025-02-24","symbol":"IBD","amount":0.0728,"announcedDate":"2025-02-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-24","defaultRemindTime":1740407400000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-03","payableDate":"2025-02-24","currency":"USD","dateTimestamp":1740373200000,"payDate":"2025-03-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBD\",market:\"US\",,,undefined,":[{"executeDate":"2017-08-16","recordDate":"2017-08-18","paymentDate":"2017-08-23","value":0.0405,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-25","value":0.0292,"currency":"USD"},{"executeDate":"2017-10-16","recordDate":"2017-10-17","paymentDate":"2017-10-23","value":0.0347,"currency":"USD"},{"executeDate":"2017-11-16","recordDate":"2017-11-17","paymentDate":"2017-11-28","value":0.0389,"currency":"USD"},{"executeDate":"2018-01-29","recordDate":"2018-01-30","paymentDate":"2018-02-05","value":0.0269,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBD\",market:\"US\",delay:false,,,undefined,":{}}}